Date published: 2026-3-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

plexin-B3 Inhibitors

Plexin-B3 inhibitors are a class of chemical compounds that selectively interact with the Plexin-B3 receptor, a transmembrane protein belonging to the broader plexin family, which plays a critical role in various intracellular signaling pathways. Plexin-B3 is particularly significant in guiding cellular communication and cytoskeletal organization, processes that are heavily influenced by its interaction with semaphorins, which are known to modulate axon guidance and other cellular responses. Inhibitors of Plexin-B3 generally function by preventing the receptor from engaging with its natural ligands, thus disrupting its downstream signaling activities. These inhibitors are designed to interfere with the receptor's extracellular ligand-binding domain or the intracellular signaling domains, which include GTPase-activating proteins (GAPs) and guanine-nucleotide exchange factors (GEFs). By inhibiting these interactions, Plexin-B3 inhibitors effectively modulate the dynamic activities of cytoskeletal rearrangement and cell motility, which are central to processes such as morphogenesis and cellular migration.

Structurally, Plexin-B3 inhibitors vary widely, but they often contain functional groups capable of establishing strong and specific binding interactions with the receptor. These compounds may target the intracellular domains to block the receptor's interactions with downstream effectors like small GTPases (such as Rac and Rho), which are pivotal in the regulation of actin cytoskeleton remodeling. Some inhibitors are designed to modify the conformational flexibility of Plexin-B3, thus preventing its activation and altering signal transduction pathways that involve various protein complexes and kinase cascades. The complexity of these interactions highlights the role of Plexin-B3 inhibitors in investigating the receptor's involvement in cellular mechanisms such as adhesion, migration, and cytoskeletal dynamics. Researchers in molecular biology and biochemistry continue to explore Plexin-B3 inhibitors as tools to dissect intricate signaling networks that govern cellular behavior, especially in systems where precise regulation of cell morphology and movement is critical.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide obstructs the elongation phase of mRNA translation in eukaryotic cells, leading to a reduction in Plexin-B3 protein synthesis.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

This compound intercalates into DNA, halting the transcription process, which would result in decreased synthesis of Plexin-B3 mRNA.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

By inhibiting histone deacetylases, Trichostatin A promotes a more open chromatin structure, potentially leading to the repression of Plexin-B3 gene expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine causes DNA demethylation, which could lead to the transcriptional silencing of the Plexin-B3 gene through changes in gene promoter accessibility.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin selectively inhibits mTOR, resulting in decreased protein translation, which includes a reduction in the synthesis of Plexin-B3.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY 294002 blocks PI3K activity, leading to a decrease in downstream signaling required for the transcription and translation of Plexin-B3.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 blocks JNK activity, which is essential for the transcriptional activation of certain genes, potentially including Plexin-B3, leading to its decreased expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 disrupts MEK activity within the MAPK pathway, leading to a decrease in Plexin-B3 mRNA due to diminished transcriptional activation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

By inhibiting p38 MAP kinase, SB 203580 could lead to reduced transcriptional activation of the Plexin-B3 gene, thereby decreasing its expression.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin inhibits phosphoinositide 3-kinases, leading to a decrease in cellular signaling pathways that promote Plexin-B3 expression.